chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration in the left arm on 17Mar2021 at 12:45 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. The patients medical history included HFpEF heart Failure (heart failure with preserved ejection fraction), pulmonary hypertension, hypothydroidism, protein S deficiency, insulin resistant and high cholesterol. The patient was allergic to demerol, morphine, levaquin, ferahem E (IV iron), humira, penicillin and hydrocodone. The concomitant medications included ELIQUIS, BYSTOLIC, losartan (MANUFACTURER UNKNOWN), nifedipine (MANUFACTURER UNKNOWN) and much more of unspecified drugs which were taken since an unspecified date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 17Mar2021, the patient experienced the first sign of eyes feeling puffy within 21 minutes of the vaccination. On 17Mar202 at 13:15, the patient had very mild sporadic itching that began on the face and neck along with slight flushing/warmth. She also felt like throat was dry throat but wasn't thirsty. All of these symptoms were within an hour and half of the vaccine. The day after vaccine, the patient still had sporadic itching and dry throat. Two days after the vaccination, the patient had a light headache that lasted for 2 days and had a onetime episode of diarrhoea with slight nausea on an unspecified date in Mar2021. Thereafter everything was good. The patient had taken Benadryl as a therapeutic measure. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of eyes feeling puffy, very mild sporadic itching on face and neck, slight flushing/warmth, dry throat, onetime episode of diarrhoea with slight nausea was recovered on an unspecified date in Mar2021 and the clinical outcome of light headache was recovered on 22Mar2021. No follow-up attempts are needed. No further information was expected.
Within 4 hours of receiving the H1N1 shot her arm was "hurting as if someone hit me" I put ice on i and heat the next day. She was then unable to move her arm and bruising started to move down her arm to her elbow. Last Coumadin level was checked on 12/8/2009. It was ok states patient. She saw Dr.
Bad cough; Trouble breathing; Tingling around mouth; Numbness in jaw and neck; Shaking; Red face and chest; Slight itching; This is a spontaneous report from a contactable healthcare professional (the patient).  A 38-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL8982), intramuscular in the left arm on 18Jan2021 at 10:30 (at the age of 38-years-old) as a single dose for Covid-19 immunization. Medical history was not reported. The patient was allergic to penicillin. The patient previously received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EJ1685) on 28Dec2020 in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ALERTEC), both for unknown indication from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jan2021 at 11:00, the patient experienced bad cough, trouble breathing, tingling around mouth, numbness in jaw and neck, shaking, red face and chest, and slight itching. Treatment was given when seen by paramedics with an emergency room visit which included a second dose of allergy medication. The clinical outcome of the events bad cough, trouble breathing, tingling around mouth, numbness in jaw and neck, shaking, red face and chest, and slight itching was recovering. It was reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: The reported events were likely causally related to the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), considering the plausible temporal relationship and clinical course of the events.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Tingly sensation on right leg; This is a spontaneous report from a contactable consumer (patient) reported for herself that. A 25-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 09May2021 17:15 (Batch/Lot Number: EW0177) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. It was reported that 24May2021, patient experienced tingly sensation on right leg. Would not want to walk at times. Regarding reaction stop date it was mentioned as it was not a regular thing anymore. It was every now and then. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 14Jan2021. Outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected
his physician is recommending that be takes SHINGREX. After already having had ZOSTAVAX 3 or 4 years ago; his physician is recommending that be takes SHINGREX. After already having had ZOSTAVAX 3 or 4 years ago; This spontaneous report was received from a male patient of unknown age who was reporting on theirself. No information regarding the patient's concurrent conditions, medical history or concomitant medications was provided. On an unknown date in approximately 2016, 3 or 4 years ago, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (exact dose, frequency, site and route of administration, lot# and expiration date were not reported). The patient stated that his physician recommended to administer zoster rge vaccine (mammalian) (SHINGRIX), reported as SHINGREX, although he had already administered a dose of zoster vaccine live (ZOSTAVAX).
I tested positive for COVID-19 on April 10, 2023, My symptoms were severe sore throat, tiredness, I was taking Tylenol and Paxlovid for my symptoms.
I am an above knee amputee. I lost my left leg to osteosarcoma 37 years ago. Since my amputation I have infrequently experienced moderate phantom limb pain (2-3 times per year). Usually it lasts a few hours (usually at night) and then resolves. 8 hours after I received my Shingrix shot, the most unrelenting phantom pain I've ever had started. Every 1-2 minutes i would have episodes of intense pain. This lasted 18 hours until a doctor prescribed Percocet. I have taken 3 Percocet tablets in the last 24 hours (the last was 10 hours ago) and I believe the pain has generally resolved, although I still have twinges.
pt recvd vax & w/in 1 wk post vax exp a fever 9100-101),flushing & arms & legs hurt;sx were treated w/APAP & subsided;
Vaccine may not have been effective, but would not be harmful.  On 9/14/23 had Temp Excursion in Med Refrig to 0* celcius.  Reported this on 9/15/23.  Vaccines were held, Vaccine companies contacted and on 9/18/23 was told by her these vaccines were safe to give including the DTAP/IVP.   But then on 9/29/23 she contacted me again at our office and said after 2nd review, the DTAP/IPV might be INEFFECTIVE after all and should contact anyone who had dose of this to notify them possibly INEFFECTIVE, but NOT HARMFUL. and that they should come back after a month to have vaccine repeated.    Called patient's mother and notified of this information. She chose to bring pt in for appt scheduled  11/3/23 at 10am to have this vaccine repeated, so appt still pending.  She did not sound upset on the phone.
Information has been received from a registered nurse concerning a white female with allergies to sulfa, penicillin, and iodine who on 2/20/02 was vaccinated with pneumococcal vaccine 23 polyvalent, IM (lot # 637487/1071K). The patient's illnesses at the time of the vaccination included vitamin B-12 deficiency, asthma, and hypertension. Subsequently, the patient experienced severe reactions. On 2/21/02, the patient's injection site became large, red and swollen. The swelling involved the arm from the elbow to under the armpit. The patient also had weaping of fluid from her arm. Additional information received from the registered nurse indicated that that the patient also developed arm edema and arm pain from her elbow to shoulder and extending into the axillary region. The patient did not develop a fever. The patient sought medical attention and was treated with ice and ibuprofen (dose and duration not reported). Subsequently, the patient recovered from large, red injection site, swollen injection site, from the elbow to under the armpit, arm edema and arm pain from her elbow to shoulder and extending into axillary region. Information was also received concerning two other patients (demographics unknown) who were vaccinated with pneumococcal vaccine 23 polyvalnt (date of vaccination unknown) (lot # 637487/1071K) (WAES0202USA02371). Follow up information was received from the registered nurse who reported that she only had information on one patient because the other physicians could not recall the names of the other two patients. The registered nurse reported that she knew that none of the patients required hospitalization and none of the patients went to the emergency room. The reporter expressed a concern regarding the lot number (1071K). The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. No further information is available.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Weakness-Medium, Additional Details: patient stated that he had  a similar reaction to his first shot but not his second shot. patient says his reaction to the first shot  went away in 30 minutes after he took enough rest. patient states he works in a healthcare setting ,and he is well aware of his reactions. patient declined the use of diphenhydramine. patient's bp was 118/79,and heart rate 73 when he left the store. patient got better after 1 hour of event.
11-13-09 received intranasal H1N1 vaccine. 11-16-09 - awoke with swollen (R) cheek & around eye. Mom gave BENADRYL which helped swelling. No fever mild sore throat in AM. Hx of seasonal allergies/occas. sneezing.
PREVNAR 13. The patient developed pneumonia within 1 month of the vaccine. This is my 2nd (of 4 patients) to develop pneumonia within 1 month.
My last period lasted for three weeks with a lot of blood clots; My last period lasted for three weeks with a lot of blood clots/Period is also very runny and watery. Bleeding through many pads per hour.; Periods after covid are irregular; This is a spontaneous report from a contactable consumer (Patient herself). A 29-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in Arm Right on 04Apr2021 12:00 (at the age of 29-years-old) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and she did not receive any other medications within 2 weeks of vaccination. Prior and since to the vaccination the patient did not diagnosed with COVID-19. On an unspecified date the patient reported that her periods after COVID are irregular. Her last period lasted for three weeks with a lot of blood clots. Some blood clots were the about the size of a golf ball. Period is also very runny and watery. Bleeding through many pads per hour. Prolonged hospitalization reported as No. The treatment received reported as no. Outcome of events was not recovered.
High fever (102-105); joint and muscle leg pain, Inconsolable high pitch screaming for days, headache, Lethargic.
Patient called us over phone to report this event. Patient said she felt pain starting about one day after the injection; the pain continue to develop over the next few days, and she went to urgent care on April 14, 2021. At urgent care, the providers made a diagnosis of SIRVA. Patient described the condition as pain, swelling, difficulty in moving arm. Patient currently rests at home after having been seen by urgent care.
A serious spontaneous report of "gave H1N1 LAIV to 30 y/o patient with childhood history of asthma" and pneumonia, which was manifested by respiratory and congestion problems, was received from a registered nurse/health professional concerning a 39-year-old, subsequent to H1N1, Intranasal. The patient had childhood history of asthma. The concomitant medications was not reported for this patient. On an unknown date in 2009, the patient received H1N1, Intranasal for an unknown indication. The patient experienced respiratory and congestion problems in mid Dec-2009. In Jan-2010, the patient stated that he had pneumonia which was related to the H1N1 LAIV. The outcome of "gave H1N1 LAIV to 30 y/o patient with childhood history of asthma" was considered to be resolved and the outcome of pneumonia was unknown.
Left deltoid injection site 1" diameter red, warm & firm. Started with itching evening before & 4" below red area no dyspnea. Chest pain of severe reaction. T 97.5 p 65 R-16 BP 110/66. Seen by Dr. Started on ZYRTEC 12mg po x 5 day & Cephalexin 500mg one po q 6 hours x 7 days.
Dizziness, tachycardia, dyspnea, redness, warmth on right arm. Checked vital signs after patient returned on 2/17/16 Temp. 97.1 BP 97/68 Pulse 73
On April 18, 2021 I woke up with severe vertigo which I had never had before it lasted approximately 16 hours. Then on April 28, 2021 I became very uncoordinated, slurred speech, depth perception was off a lot of neuropathic pain something just wasn?t right. Was check to make sure I wasn?t having a stroke, and I followed up with my primary care. For seven days I couldn?t drive I couldn?t walk without assistance and my whole world was in just an upside down moment. My primary care physician ordered an MRI and a ton of bloodwork to see if it was possibly MS. The MRI came back negative with a normal brain scan but my blood work came back positive for neuromyelitis optica  NMO for short. I have never had a history of any form of autoimmune disease. Demyelinating disease nothing like that. My whole world is literally shattering around me because now I?ve been diagnosed with this NMO, And trying to find a provider that can possibly help me with such a very rare autoimmune disorder. The more I read about the COVID-19 vaccine I think the Covid vaccine has caused this rare disorder and I?m scared to death I don?t want anyone else to have to go through this.
This case meets vaccine breakthrough criteria review.  SxS falls, diarrhea, fevers, poor appetite, increased confusion.
Information has been received from a health care worker concerning a female who on an unspecified date was vaccinated with 0.5 ml a first dose of GARDASIL (route and lot number not reported). In the "past two weeks" (approximately on 16-MAR-2010) was vaccinated with 0.5 ml a second dose of GARDASIL (route and lot number not reported). The health care worker stated that "the patient developed flu like symptoms and she felt down and out after received her first and second dose of GARDASIL" "with in the same date of receiving the vaccine" (approximately on 16-MAR-2010). At the time of the report the outcome of the patient was unknown. The patient sought unspecified medical attention. Additional information has been requested.
Patient received flu and penumonia vaccine on 10/24/07, she called her son at 6am on 10/25/07 and complained of itching, son saw her at 8:30am noticed rash on her arm and torso and upper leg. Her son gave her topical hydrocortisone cream and 1 dose of benadryl capsule 25mg. Patient stated having the flu shot given before with no problems.
Severe nausea and body aches. Fever with sweating and chills. Metallic taste in my mouth. Arm soreness. These side effects lasted for about 12 hours,
first dose 3 days after ending her period/ next period 5 days after her vaccine.; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on unknown date. Medical history and concomitant medication were not reported. The patient had COVID 19 vaccine 3 days after ending her period. She then started her next period 5 days after her vaccine. The patient stated that she had a very regular cycle, so this was not normal for her. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Diffuse body rash, macular papular arms, trunk, neck, legs. Also had achiness and fatigue.
8 hours post vax pt developed a temperature of 101; severe abdominal pain; back pain; shoulder pain; and nausea.
Patient was only 17 years old, at the time of vaccination was not confirmed that patient qualified for the vaccine, patient's mother has signed the consent form, patient and mother has the same name and last name.
Intussusception. Failed reduction. Required surgical resection.  9/14/09 Hospital records received DOS 8/27/09 to 8/31/09. Assessment: Intussusception. Infant presents with three days vomiting, poor oral intake, dehydration, diarrhea. On admission projectile vomiting. Blood tinged stool. Unable to reduce intussusception via air enema. Exploratory laparotomy, reducable intussusception, ileocecectomy. Initially febrile post-op, steadily improved, good po intake with return of bowel function.   ICD-9 Codes: 580.0 Intussusception, 285.1 AC Posthemorrhagic anemia, 997.4 Digestive system complication, 560.1 Paralytic ileus, E878.8 Abn React-Surg Proc nec.
PATIENT WITH SIMILAR NAME GOT THE THIRD SHOT OF PFIZER PEDIATRIC DOSE BY ACCIDENT. THERE IS NO KNOWN SYMPTOMS AFTER THE THIRD SHOT OF THE VACCINE.
Patient qualified for COVID 19 vaccine. Care documents did not have prior documented doses. Patient was consented and administered the vaccine but then the nursing home reported he had received 2 doses of Pfizer vaccine in the nursing home.  No current adverse events after monitoring post vaccine
Pt vitiligo has been in remission for 4 years.  Right after the vaccine she felt tingling through her whole arm and body.  Later her shoulder hurt.   But the part that concerns me is a few days later the skin on the back of her leg that had been previously stable started turning white with red bumps.  It became aggravated as in her early days of vitiligo.
Supraclavicular lymph node swollen to approximate size of a quarter on the left side (same side as the injection arm).
dry cough / coughing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of COUGH (dry cough / coughing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (dry cough / coughing). At the time of the report, COUGH (dry cough / coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
I had weakness and pain in both of my knees due to arthritis that I've had for years. I get an annual cortisone shot, and this time it felt like I never had one. This prevented me from walking up and down the stairs. I did have some shortness of breath too. I had caught COVID-19 so I got my cortisone shot a week later on January 27, 2022. To this day the cortisone shot that I received feels like it has no effect on me because I still have constant pain in my knees. So far since getting the vaccine the cortisone shot has not been effective.
Random grimacing (may have been present before the immunization). Fever off and on for one week, runny nose, fussy onset week after immunization. Poor eating-milk only (decreased). Poor sleeping.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 29-MAY-2018, the patient was vaccinated with an improperly stored dose of PEDVAXHIB lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009026: US-009507513-1806USA009027: US-009507513-1806USA009028: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009033: US-009507513-1806USA009034: US-009507513-1806USA009035: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009038: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056.